NDC 70518-4035-01 - Glyburide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4035
- Requested NDC
- 70518-4035-01
- Package NDCs from labels
- 70518-4035-0, 70518-4035-1, 70518-4035-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-06-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYBURIDE TABLETS, USP For Oral Use 1.25, 2.5, and 5 mg | REMEDYREPACK INC. | 2026-06-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4035-0 | Glyburide | 30 in 1 BLISTER PACK | TABLET | 30 | 3 | |
| 70518-4035-1 | Glyburide | 360 in 1 BOTTLE, PLASTIC | TABLET | 360 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-4035 | GLYBURIDE TABLET [REMEDYREPACK INC.] | 1 | Current NDC, 2 package rows | 20240312_524eec41-37ee-419a-b7a1-d23e888ae6ab.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glyburide | GLYBURIDE | NuCare Pharmaceuticals, Inc. | 21786ac0-da3c-16cb-e063-6394a90a4596 | 2024-09-06 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| Glyburide | GLYBURIDE | NuCare Pharmaceuticals, Inc. | 3e354b4d-70e4-5089-e054-00144ff88e88 | 2024-08-13 | Adverse reactions | 310537 SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | NuCare Pharmaceuticals,Inc. | a12342fb-123c-2951-e053-2a95a90ac596 | 2024-06-20 | Adverse reactions | 310537 SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | NuCare Pharmaceuticals,Inc. | a1233548-bbb8-34aa-e053-2a95a90aea53 | 2024-06-20 | Adverse reactions | 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | NuCare Pharmaceuticals,Inc. | 901c50d5-31e7-b073-e053-2995a90abfeb | 2024-06-19 | Adverse reactions | 310537 SX6K58TVWC |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 7facb5ac-c1d5-43b4-e053-2991aa0a2a7b | 2024-06-12 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | 8f2951ab-20c3-4216-b250-4c6a62d32203 | 2024-05-30 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| Glyburide | GLYBURIDE | A-S Medication Solutions | d090f978-b1a5-4db7-951d-3f32dd06966c | 2024-01-02 | Warnings, Adverse reactions | ANDA203379 310537 SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | A-S Medication Solutions | 7a280f88-26d4-4fe5-a89b-a6f1d90ed3cd | 2023-12-03 | Adverse reactions | 310534 SX6K58TVWC |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | H3R47K3TBD |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | H3R47K3TBD |
| Glyburide | GLYBURIDE | A-S Medication Solutions | 922d1080-52c6-41e4-a310-533d8ca18594 | 2023-08-28 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | A-S Medication Solutions | 3c91a408-973b-4572-832f-515f61d5be1f | 2023-02-04 | Adverse reactions | 310537 SX6K58TVWC |
| Glyburide | GLYBURIDE | Teva Pharmaceuticals USA, Inc. | e84c0dfc-a4e9-4c89-b6ea-45732eb412f5 | 2023-01-09 | Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide | GLYBURIDE | Cadila Pharmaceuticals Limited | ea7a055b-64f0-46bf-aa8e-4a2ef5c3c035 | 2022-12-29 | Warnings, Adverse reactions | ANDA203379 310537 197737 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | Modavar Pharmaceuticals LLC | a5de0ef6-4c8b-40ab-b0ed-2003a8086750 | 2022-12-29 | Warnings, Adverse reactions | ANDA203379 72241-040 310537 197737 310534 7ebf5b06-fdd3-4120-93f2-d31def5bf104 a5de0ef6-4c8b-40ab-b0ed-2003a8086750 SX6K58TVWC |
| glyburide | GLYBURIDE | Zydus Lifesciences Limited | 5d0e406f-285d-4716-8971-82f665345517 | 2022-11-16 | Adverse reactions | 310537 197737 310534 SX6K58TVWC |
| glyburide | GLYBURIDE | Zydus Pharmaceuticals (USA) Inc. | 87781ea8-62ec-483c-a4dd-8c965ce59485 | 2022-11-16 | Adverse reactions | 310537 197737 310534 SX6K58TVWC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.